Greenleaf Peter has filed 17 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 25478 shares of Pelthos Therapeutics Inc. ($PTHS) on July 02, 2025.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Greenleaf Peter | Director | A | Common Stock | 25478 | $0.00 | 25,478.0000 | 6,103,813 | 9999.99% | 0.42% |
| Feb. 27, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | A | Employee Stock Option (right to buy) | 328424 | $0.00 | 328,424.0000 | 138,959,000 | 9999.99% | 0.24% |
| March 2, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | F | Common Stock | 100890 | $14.21 | 1,840,379.0000 | 138,959,000 | 5.20% | 0.07% |
| Feb. 27, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 196403 | $0.00 | 1,941,269.0000 | 138,959,000 | 11.26% | 0.14% |
| Feb. 20, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | F | Common Stock | 100171 | $14.40 | 1,744,866.0000 | 138,959,000 | 5.43% | 0.07% |
| Jan. 2, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | F | Common Stock | 113169 | $15.95 | 1,845,037.0000 | 138,959,000 | 5.78% | 0.08% |
| Jan. 2, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 165384 | $0.00 | 1,954,329.0000 | 138,959,000 | 9.24% | 0.12% |
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Greenleaf Peter | Director | A | Stock Option | 77640 | $0.00 | 77,640.0000 | 6,103,813 | 9999.99% | 1.27% |
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Greenleaf Peter | Director | A | Restricted Stock Units | 25478 | $0.00 | 25,478.0000 | 6,103,813 | 9999.99% | 0.42% |
| Feb. 28, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 290728 | $0.00 | 1,815,780.0000 | 146,194,000 | 19.06% | 0.20% |
| March 4, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | S | Common Stock | 164947 | $7.92 | 1,788,945.0000 | 146,194,000 | 8.44% | 0.11% |
| March 3, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | S | Common Stock | 195593 | $8.00 | 1,953,892.0000 | 146,194,000 | 9.10% | 0.13% |
| Feb. 28, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | A | Employee Stock Option (right to buy) | 443973 | $0.00 | 443,973.0000 | 146,194,000 | 9999.99% | 0.30% |
| March 3, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 333705 | $0.00 | 2,149,485.0000 | 146,194,000 | 18.38% | 0.23% |
| March 6, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | S | Common Stock | 126981 | $5.60 | 1,522,114.0000 | 143,236,000 | 7.70% | 0.09% |
| Feb. 20, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 661538 | $0.00 | 1,649,095.0000 | 143,236,000 | 66.99% | 0.46% |
| March 2, 2023 | Aurinia Pharmaceuticals Inc. | $AUPH | Greenleaf Peter | Chief Executive Officer | S | Common Stock | 33047 | $8.78 | 982,671.0000 | 141,915,000 | 3.25% | 0.02% |